hk-ipo/data/extracted_text/02629/allotment_results_2025-05-22_2025052201535.txt

--- page 1 ---
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock
Exchange”) and Hong Kong Securities Clearing Company Limited (“ HKSCC”) take no responsibility for
the contents of this announcement, make no representation as to its accuracy or completeness and expressly
disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any
part of the contents of this announcement.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings
as those defined in the prospectus dated May 15, 2025 (the “ Prospectus”) issued by Mirxes Holding
Company Limited (the “Company”).

This announcement is for information purposes only and does  not constitute an offer or an invitation to
induce an offer by any person to acquire, purchase or subscribe for any securities of the Company. This
announcement is not a prospectus. Potential investors should read the Prospectus for detailed information
about the Company and the Global Offering described below before deciding whether or not to invest in the
Offer Shares.

This announcement is not for release, publication, distribution, directly or indirectly, in or into the United
States (including its territories and possessions, any state of the United States and the District of Columbia)
or to any person (as defined in Regulation S under the U.S. Securities Act of 1933, as amended from time to
time, (the “ U.S. Securities Act ”)) or any o ther jurisdiction where such distribution is prohibited by law.
This announcement does not constitute or form a part of any offer to sell or solicitation to purchase or
subscribe for securities in the United States or in any other jurisdictions. Any investment decision in relation
to the Offer Shares should be taken solely in reliance on the information in the Prospectus.

The Offer Shares have not been, and will not be, registered under the U.S. Securities Act or any state
securities law of the United Stat es and may not be offered, sold, pledged or transferred within the United
States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements
of the U.S. Securities Act. The Offer Shares are being offered and sold outside the United States in offshore
transactions in reliance on Regulation S under the U.S. Securities Act. There will be no public offer of
securities in the United States.

Potential investors of the Offer Shares should note that the Joint Sponsors a nd the Joint Overall
Coordinators (for themselves and on behalf of the Hong Kong Underwriters) shall be entitled to terminate
their obligations under the Hong Kong Underwriting Agreement with immediate effect upon the occurrence
of any of the events set ou t in the section headed “Underwriting – Underwriting Arrangements and
Expenses – Hong Kong Public Offering – Grounds for Termination” in the Prospectus at any time prior to
8:00 a.m. (Hong Kong time) on the Listing Date (which is currently expected to be o n Friday, May 23,
2025).


--- page 2 ---
1
Mirxes Holding Company Limited
(Incorporated in the Cayman Islands with limited liability)
Global Offering
Number of Offer Shares under
the Global Offering
: 46,620,000 Shares
Number of Hong Kong Offer Shares : 5,873,700 Shares (as adjusted after
reallocation)
Number of International Offer Shares : 40,746,300 Shares (as adjusted after
reallocation)
Offer Price : HK$23.30 per Offer Share, plus brokerage
fee of 1.0%, SFC transaction levy of
0.0027%, Stock Exchange trading fee of
0.00565% and AFRC transaction levy of
0.00015% (payable in full on application
in Hong Kong dollars, subject to refund)
Nominal value : US$0.00001 per Share
Stock code : 2629
Joint Sponsors, Sponsor-Overall Coordinators, Joint Global Coordinators,
Joint Bookrunners and Joint Lead Managers
Joint Overall Coordinators, Joint Global Coordinators,
Joint Bookrunners and Joint Lead Managers
Joint Bookrunners and Joint Lead Managers
Joint Lead Managers


--- page 3 ---
MIRXES HOLDING COMPANY LIMITED
ANNOUNCEMENT OF ALLOTMENT RESULTS

Warning: In view of high concentration of shareholding in a small number of
Shareholders, Shareholders and prospective investors should be aware that the price
of the Shares could move substantially even with a small number of Shares traded and
should exercise extreme caution when dealing in the Shares.
SUMMARY
Company Information
Stock code 2629
Stock short name MIRXES-B
Dealings commencement date May 23, 2025*
* see note at the end of the announcement
Price Information
Final Offer Price HK$23.30
Offer Price Adjustment exercised N/A

Offer Shares and Share Capital
Number of Offer Shares 46,620,000
Number of Offer Shares in Hong Kong Public
Offering (after reallocation) 5,873,700
Number of Offer Shares in International Offering
(after reallocation) 40,746,300
Number of issued Shares upon Listing  276,342,331

Over-allocation
No. of Offer Shares over-allocated N/A

Proceeds
Gross proceeds (Note) HK$1,086.2 million
Less: Estimated listing expenses payable
based on Final Offer Price
HK$(205.8) million
Net proceeds HK$880.5 million
Note: Gross proceeds refers to the amount to which the Company is entitled to receive.
For details of the use of proceeds, please refer to section headed “Future Plans and Use
of Proceeds” in the Prospectus dated May 15, 2025. During the Track Record Period, the
listing expenses of approximately US$8.6 million has been charged to the consolidated
statements of profit or loss and other comprehensive income of the Company.


--- page 4 ---
ALLOTMENT RESULTS DETAILS

HONG KONG PUBLIC OFFERING


No. of valid applications 21,541
No. of successful applications 21,025
Subscription level 25.51 times
Claw-back triggered No
No. of Offer Shares initially available under the Hong
Kong Public Offering
4,662,000
Final no. of Offer Shares under the Hong Kong Public
Offering
5,873,700
% of Offer Shares under the Hong Kong Public
Offering to the Global Offering
12.60%

Note: For details of the final allocation of Shares to the Hong Kong Public Offering,
investors can refer to www.eipo.com.hk/eIPOAllotment to perform a search by identification
number or  www.eipo.com.hk/eIPOAllotment for the full list of allottees.

INTERNATIONAL OFFERING


No. of placees 116
Subscription Level 0.98 times
No. of Offer Shares initially available under the
International Offering
41,958,000
Final no. of Offer Shares under the International Offering 40,746,300
% of Offer Shares under the International Offering to
the Global Offering
87.40%

The Directors confirm that, to the best of their knowledge, information and belief, none of the
Offer Shares subscribed by the placees and the public have been financed directly or indirectly
by the Company, any of the Directors, chief executive of the Company, co-founders, substantial
Shareholders, existing Shareholders of the Company or any of its subsidiaries or their
respective close associates; and none of the placees and the public who have purchased the
Offer Shares are accustomed to taking instructi ons from the Company, any of the Directors,
chief executive of the Company, co-founders, substantial Shareholders, existing Shareholders
of the Company or any of its subsidiaries or their respective close associates in relation to the
acquisition, disposal, voting or other disposition of Shares registered in his/her/its name or
otherwise held by him/her/it.

The placees in the International Offering include the following:


--- page 5 ---
Cornerstone Investors

Investor Note 1 No. of Offer
Shares allocated
% of Offer
Shares

% of total
issued
Shares after
the Global
Offering
Existing
shareholders
or
their close
associates
Beijing Xunrui
Enterprise
Management
Partnership
(Limited
Partnership)
(“Beijing
Xunrui”) /
北京潯瑞企業管
理合夥企業(有
限合夥)（“北
京潯瑞”） 16,649,200 35.71% 6.03% No
Evergreen Gate
Limited
(“Evergreen
Gate”) 2,637,200 5.66% 0.95% No
Total 19,286,400 41.37% 6.98%
Note:
1. For further details of the Cornerstone Investors, please refer to the section headed
“Cornerstone Investors” in the Prospectus.


--- page 6 ---
LOCK-UP UNDERTAKINGS
Pre-IPO Investors (as defined in the “History, Reorganization and Corporate Structure”
section of the Prospectus)
Name Number of Shares
held in the Company
subject to lock-up
undertakings upon
Listing
% of shareholding in
the
Company subject to
lock-up
undertakings upon
Listing
Last day subject to
the lock-up
undertakings Note 1
Central Road Holdings
Limited
50,608,154 18.31% February 23, 2026
Octenniel Corporation
Pte. Ltd.
10,569,944 3.82% February 23, 2026
Beijing Fupu Changji
Enterprise
Management
Partnership (Limited
Partnership) /北京複朴
長吉企業管理合夥企
業 (有限合夥) 7,657,411 2.77% February 23, 2026
Capstar Management
Group Limited
4,324,000 1.56% February 23, 2026
Kinetic Creation
Global Investments
Limited /建成開元投
資有限公司 4,324,000 1.56% February 23, 2026
Rock Springs Capital
Master Fund LP Note 2
4,324,000 1.56% February 23, 2026
Four Pines Master
Fund LP Note 2 864,800 0.31% February 23, 2026
EDB Investments Pte
Ltd 4,076,353 1.48% February 23, 2026
Banyan Partners Fund
III, L.P. Note 3 3,995,000 1.45% February 23, 2026
Banyan Partners Fund
III-A, L.P. Note 3
705,000 0.26% February 23, 2026
Accelerate Venture
Creation Pte. Ltd. Note 4 765,741 0.28% February 23, 2026
Jane Street Global
Trading, LLC
3,459,200 1.25% February 23, 2026


--- page 7 ---
NHH Venture Fund,
L.P. 2,353,435 0.85% February 23, 2026
Alpha Win IX LPF /中
源九號有限合夥基金
Note 5 2,162,000 0.78% February 23, 2026
SDG Alpha Win PE
LPF Note 5 432,400 0.16% February 23, 2026
Divine Limited
2,162,000 0.78% February 23, 2026
Keytone Collaboration
II, L.P. Note 6
2,162,000 0.78% February 23, 2026
Keytone Ventures III,
L.P. Note 6
2,162,000 0.78% February 23, 2026
CDG Group Fund L.P.
Note 7
64,860 0.02% February 23, 2026
CRF Investment
Holdings Company
Limited Note 7 2,097,140 0.76% February 23, 2026
IGBE Tech Pte. Ltd.
1,914,353 0.69% February 23, 2026
Mitsui & Co., LTD
1,914,353 0.69% February 23, 2026
RDS1 Holdings Pte.
Ltd. 1,914,353 0.69% February 23, 2026
Jubilant Peace
Investments Pte. Ltd. 1,297,200 0.47% February 23, 2026
Blue Spark Hub Pte.
Ltd. 1,148,612 0.42% February 23, 2026
BPC SPV MRX
LIMITED 1,081,000 0.39% February 23, 2026
China Chengtong
Investment Company
Limited /
中國誠通投資有限公
司 864,800 0.31% February 23, 2026
Denning Holdings
Limited
864,800 0.31% February 23, 2026
Ebco Capital Pte. Ltd.
432,400 0.16% February 23, 2026
Knowledge World Co.
Ltd.
216,200 0.08% February 23, 2026


--- page 8 ---
JASS Assets Limited
Liability Partnership
191,435 0.07% February 23, 2026
Total 121,108,944 43.83%
Notes:
1. Each of the Pre-IPO Investors has entered into a deed of lock-up undertaking in
favor of the Company and the Joint Sponsors pursuant to which certain lock-
up restrictions have been imposed on its Shares during period ending on the
date that is nine months from the Listing Date. For details, please refer to the
section headed “History, Reorganization and Corporate Structure —
Pre-IPO
Investments” in the Prospectus.
2. Rock Springs Capital Master Fund LP and Four Pines Master Fund LP in
aggregate will hold 5,188,800 Shares which represent approximately 1.87% of the
total issued share capital of the Company upon Listing.
3. Banyan Partners Fund III, L.P. and Banyan Partners Fund III-A, L.P. will hold
4,700,000 Shares in aggregate which represent approximately 1.71% of the
total issued share capital of the Company upon Listing.
4. Accelerate Venture Creation Pte. Ltd. and Accelerate Technologies Pte. Ltd. in
aggregate will hold 4,662,686 Shares which represent approximately 1.69% of the
total issued share capital of the Company upon Listing.
5. Alpha Win IX LPF and SDG Alpha Win PE LPF in aggregate will hold
2,594,400 Shares which represent approximately 0.94% of the total issued
share capital of the Company upon Listing.
6. Keytone Collaboration II, L.P. and Keytone Ventures III, L.P. in aggregate will
hold 4,324,000 Shares which represent approximately 1.56% of the total issued
share capital of the Company upon Listing.
7. CRF Investment Holdings Company Limited and CDG Group Fund L.P. in
aggregate will hold 2,162,000 Shares which represent approximately 0.78% of the
total issued share capital of the Company upon Listing.


--- page 9 ---
Cornerstone Investors

Name Number of
Shares held in the
Company subject
to lock-up
undertakings
upon Listing
% of total issued
Shares after the
Global Offering
subject to lock-up
undertakings upon
Listing
Last day subject
to the lock-up
undertakings
Note
Beijing Xunrui /北京
潯瑞 16,649,200
6.03% November 23, 2025
Evergreen Gate
2,637,200 0.95%  November 23, 2025
Total 19,286,400 6.98%
Note:
In accordance with the relevant cornerstone investment agreements, the required lock-up ends
on November 23, 2025. The Cornerstone Investors will cease to be prohibited from disposing
of or transferring Shares subscribed for pursuant to the relevant cornerstone investment
agreements after the indicated date.

Other Existing Shareholders

Name Number of Shares
held in the Company
subject to lock-up
undertakings upon
Listing
% of shareholding in
the
Company subject to
lock-up
undertakings upon
Listing

Last day subject to
the lock-up
undertakings
TOO Heng Phon /朱興
奮 Note 2 32,419,381 11.73% February 23, 2026 Note
1
SLW Gene Limited Note
3 18,660,556 6.75% February 23, 2026 Note
1
Accurate Gene Limited
Note 4 17,860,556 6.46% February 23, 2026 Note
1
MSEA Ltd Note 5
15,160,000 5.49% February 23, 2026 Note
1
HO Hou Chiat, Isaac /
何豪傑 Note 6 11,922,924 4.31%
February 23, 2026 Note
1
CAI Wensheng
4,338,462 1.57%
February 23, 2026 Note
1
Accelerate
Technologies Pte. Ltd.
Note 7 3,896,945 1.41%
February 23, 2026 Note
1
HO Yoon Khei
2,662,563 0.96% February 23, 2026 Note
1


--- page 10 ---
CHEONG Kok Yew
846,000 0.31% February 23, 2026 Note
1
ONG Jeong Shing
(WANG Jiongxing)
846,000 0.31% February 23, 2026 Note
1
Total 108,613,387 39.30%

Notes:
1. Each of the Other Existing Shareholders has entered into a deed of lock-up undertaking in
favor of the Company and the Joint Sponsors pursuant to which certain lock-up restrictions
have been imposed on its Shares during period ending on the date that is nine months from
the Listing Date.
2. Dr. TOO Heng Phon is one of the co-founders, a non-executive Director and the Chairman of
the Board of the Company.
3. SLW Gene Limited is a wholly-owned subsidiary of SLW Gene Holding Ltd, which is in turn
wholly owned by Frandor Limited. Frandor Limited is a nominee shareholder holding shares
of SLW Gene Holding Ltd on behalf of The SLW Trust, and is wholly owned by Trident,
which is the trustee of The SLW Trust, of which the settlor is Dr. Zhou Lihan, one of the co-
founders, an executive Director and the Chief Executive Officer of the Company (“Dr.
Zhou”). The beneficiaries of The SLW Trust are Dr. Zhou together with his relatives.
4. Accurate Gene Limited is a wholly-owned subsidiary of Accurate Gene Holding Ltd, which is
in turn wholly owned by Frandor Limited. Frandor Limited is a nominee shareholder holding
shares of Accurate Gene Holding Ltd on behalf of The Accurate Gene Trust and is wholly
owned by Trident, which is the trustee of The Accurate Gene Trust, of which the settlor is Dr.
Zou Ruiyang, one of the co-founders, an executive Director and the Chief Technology Officer
of the Company (“Dr. Zou”). The beneficiaries of The Accurate Gene Trust are Dr. Zou
together with his relatives.
5. MSEA Ltd is wholly owned by Frandor Limited. Frandor Limited is a nominee shareholder
holding shares of MSEA Ltd on behalf of The Mirxes Holding Pre-IPO Share Award Trust
and is wholly owned by Trident, which is the trustee of The Mirxes Holding Pre-IPO Share
Award Trust, of which Dr. Zhou and Dr. Zou are settlors and the beneficiaries are the
participants and grantees in the Pre-IPO First Share Award Scheme and the Pre-IPO Second
Share Award Scheme.
6. Mr. HO Hou Chiat, Isaac is an executive Director and the Chief Investment Officer of the
Company.
7. Accelerate Venture Creation Pte. Ltd. is a subsidiary of Accelerate Technologies Pte. Ltd.


--- page 11 ---
PLACEE CONCENTRATION ANALYSIS
Placees* Number of
Shares allotted
Allotment as % of
International Offering

Allotment as % of total
Offer Shares
Number of Shares held
upon Listing
% of total issued share
capital upon Listing
Top 1 16,649,200 40.86 35.71 16,649,200 6.02
Top 5 31,006,900 76.10 66.51 31,006,900 11.22
Top 10 36,940,900 90.66 79.24 36,940,900 13.37
Top 25 40,707,300 99.90 87.32 40,707,300 14.73

Note:
* Ranking of placees is based on the number of Shares allotted to the placees.

SHAREHOLDER CONCENTRATION ANALYSIS


Shareholders*
Number of
Shares allotted
Allotment as % of
International Offering
Allotment as % of total
Offer Shares
Number of Shares held
upon Listing
% of total issued share
capital upon
Listing
Top 1 0 0.00 0.00 50,608,154 18.31
Top 5 16,649,200 40.86 35.71 136,197,847 49.29
Top 10 23,306,700 57.20 49.99 188,165,626 68.09
Top 25 29,011,900 71.20 62.23 243,040,725 87.95

Note:
* Ranking of Shareholders is based on the number of Shares held by the Shareholders upon Listing.


--- page 12 ---
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the Prospectus, a total of 21,541
valid applications made by the public will be conditionally allocated on the basis set out
below:

NO. OF
SHARES
APPLIED
FOR
NO. OF VALID
APPLICATIONS
BASIS OF
ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTED OF
THE TOTAL
NO. OF SHARES
APPLIED FOR
POOL A
100 9,107
8,652 out of 9,107 to receive
100 Shares 95.00%
200 1,856
1,811 out of 1,856 to receive
100 Shares 48.79%
300 1,577
1,561 out of 1,577 to receive
100 Shares 33.00%
400 783 100 Shares 25.00%
500 989
100 Shares plus 49 out of
989 to receive additional 100
Shares 20.99%
600 290
100 Shares plus 23 out of
290 to receive additional 100
Shares 17.99%
700 169
100 Shares plus 20 out of
169 to receive additional 100
Shares 15.98%
800 264
100 Shares plus 32 out of
264 to receive additional 100
Shares 14.02%
900 186
100 Shares plus 32 out of
186 to receive additional 100
Shares 13.02%
1,000 1,810
100 Shares plus 362 out of
1,810 to receive additional
100 Shares 12.00%
2,000 951
100 Shares plus 380 out of
951 to receive additional 100
Shares 7.00%
3,000 387
100 Shares plus 194 out of
387 to receive additional 100
Shares 5.00%
4,000 325
100 Shares plus 195 out of
325 to receive additional 100
Shares 4.00%
5,000 509
100 Shares plus 382 out of
509 to receive additional 100
Shares 3.50%
6,000 171
100 Shares plus 137 out of
171 to receive additional 100
Shares 3.00%


--- page 13 ---
7,000 136
200 Shares plus 4 out of  136
to receive additional 100
Shares 2.90%
8,000 159
200 Shares plus 38 out of
159 to receive additional 100
Shares 2.80%
9,000 106
200 Shares plus 46 out of
106 to receive additional 100
Shares 2.70%
10,000 799
200 Shares plus 400 out of
799 to receive additional 100
Shares 2.50%
20,000 310 400 Shares 2.00%
30,000 131
400 Shares plus 66 out of
131 to receive additional 100
Shares 1.50%
40,000 61
500 Shares plus 37 out of  61
to receive additional 100
Shares 1.40%
50,000 208
600 Shares plus 104 out of
208 to receive additional 100
Shares 1.30%
100,000 82 1,200 Shares 1.20%
150,000 26
1,600 Shares plus 13 out of
26 to receive additional 100
Shares 1.10%
200,000 44 2,000 Shares 1.00%
 21,436  Total number of Pool A
successful applicants:
20,920

POOL B
250,000 61
14,400 Shares plus 32 out of
61 to receive additional 100
Shares 5.78%
300,000 10
17,300 Shares plus 4 out of
10 to receive additional 100
Shares 5.78%
350,000 3
20,200 Shares plus 1 out of  3
to receive additional 100
Shares 5.78%
400,000 2 23,100 Shares 5.78%
450,000 8
25,900 Shares plus 5 out of  8
to receive additional 100
Shares 5.77%
500,000 7
28,800 Shares plus 4 out of  7
to receive additional 100
Shares 5.77%
600,000 2 34,600 Shares 5.77%
700,000 1 40,400 Shares 5.77%
1,000,000 2 57,700 Shares 5.77%
1,500,000 1 86,600 Shares 5.77%
2,000,000 1 115,400 Shares 5.77%


--- page 14 ---
2,331,000 7
134,000 Shares plus 2 out of
7 to receive additional 100
Shares 5.75%
 105  Total number of Pool B
successful applicants:
105


As of the date of this announcement, the relevant subscription monies previously deposited in
the designated nominee accounts have been remitted back to the accounts of all HKSCC
participants. Investors should contact their relevant brokers for any inquiries.

COMPLIANCE WITH LISTING RULES AND GUIDANCE

The Directors confirm that, except for the Listing Rules that have been waived, the Company
has complied with the Listing  Rules and guidance materials in relation to the placing,
allotment and listing of the Company’s Shares.

The Directors confirm that, to the best of their knowledge, the consideration paid by the placees
or the public (as the case may be) directly or indirectly for each Offer Share subscribed for or
purchased by them was the same as the final Offer Pr ice in addition to any brokerage, AFRC
transaction levy, SFC transaction levy and Stock Exchange trading fee payable.

REALLOCATION

As the International Offer Shares are undersubscribed and the Hong Kong Public Offer Shares
are oversubscribed, the reallocation procedure as disclosed in the section headed “Structure of
the Global Offering — The Hong Kong Public Offering — Reallocation” of the Prospectus has
been applied.

As a result of such reallocation, the final number of Offer Shares under the Hong Kong Public
Offering is adjusted to 5,873,700 Shares, representing 12.6% of the total number  of Offer
Shares available under the Global Offering.


--- page 15 ---
DISCLAIMERS

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited
and Hong Kong Securities Clearing Company Limited take no responsibility for the
contents of this announcement, make no representation as to its accuracy or completeness
and expressly disclaim any liability whatsoever for any loss howsoever arising from or in
reliance upon the whole or any part of the contents of this announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or
into the United States (including its territories and possessions, any state of the United
States and the District of Columbia). This announcement does not constitute or form a part
of any offer or solicitation to purchase or subscribe for securities in the United States. The
securities mentioned herein have not been, and will not be, registered under the United
States Securities Act of 1933, as amended (the “ U.S. Securities Act”). The securities may
not be offered or sold in the United States except pursuant to an exemption from the
registration requirements of the U.S. Securities Act and in compliance with any applicable
state securities laws, or outside the United States unless in compliance with Regulation S
under the U.S. Securities Act. There will be no public offer of securities in the United States.
The Offer Shares are being offered and sold outside the United States in offshore
transactions in reliance on Regulation S under the U.S. Securities Act.
This announcement is for information purposes only and does not constitute an invitation
or offer to acquire, purchase or subscribe for securities. This announcement is not a
prospectus. Potential investors should read the Prospectus dated May  15, 2025 issued by
Mirxes Holding Company Limited for detailed information about the Global Offering
described below before deciding whether  or not to invest in the Shares thereby being
offered.
*Potential investors of the Offer Shares should note that the Joint Sponsors and the  Joint
Overall Coordinators (for themselves and on behalf of the Hong Kong Underwriters) shall
be entitled to terminate their obligations under the Hong Kong Underwriting Agreement
with immediate effect upon the occurrence of any of the events set out in the section headed
“Underwriting – Underwriting Arrangements and Expenses – Hong Kong Public Offering
–Grounds for Termination” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong
time) on the Listing Date (which is currently expected to be on May 23, 2025).


--- page 16 ---
PUBLIC FLOAT

Immediately following the completion of the Global Offering, 129,710,760  Shares held
or controlled by our Shareholders who are not our core connected persons, representing
approximately 46.94 % of our total issued Shares,  will be held in the public hands .
Therefore , the number of Shares in the public hands represents no less than 25%  of the
total issued share capital of the Company, satisfying the minimum percentage
requirement in compliance with Rule 8.08(1) of the Listing Rules.

The Directors confirm that, immediately following the completion of the Global
Offering, (i) no placee will, individually, be placed more than 10% of the enlarged
issued share capital of the Company immediately after the Global Offering; (ii) there
will not be any new substantial Shareholder immediately after the Global Offering; (iii)
the three largest pub lic Shareholders do not hold more than 50% of the Shares held in
the public hands at the time of the Listing in compliance with Rules 8.08(3) and 8.24
of the Listing Rules; and (iv) there will be at least 300 Shareholders at the time of the
Listing in comp liance with Rule 8.08(2) of the Listing Rules.

COMMENCEMENT OF DEALINGS

The Share certificates will only become valid evidence of title at 8:00 a.m. on Friday ,
May 23 , 2025 (Hong Kong time), provided that the Global Offering has become
unconditional and the right of termination described in the section headed “Underwriting
– Underwriting Arrangements and Expenses – Hong Kong Public Offering – Grounds
for Termination” i n the Prospectus has not been exercised. Investors who trade the
Shares on the basis of publicly available allocation details prior to the receipt of Share
certificates or prior to the Share certificates becoming valid evidence of title do so
entirely at t heir own risk.

Assuming that Hong Kong Public Offering  becomes unconditional at or before 8:00
a.m. on Friday, May 23 , 2025 (Hong Kong time), it is expected that dealings in the
Shares on the Stock Exchange will commence at 9:00 a.m. on Friday, May 23 , 20 25.
The Shares will be traded in board lots of 100 Shares each, and the stock code of the
Shares will be 2629 .

By order of the Board
Mirxes Holding Company Limited
Dr. ZHOU Lihan
Executive Director and Chief Executive Officer

Hong Kong, May 22, 2025

As at the date of this announcement, the Board comprises (i) Dr. ZHOU Lihan, Dr.
ZOU Ruiyang and Mr. HO Hou Chiat, Isaac as executive Directors; (ii) Dr. TOO Heng
Phon, Dr. LE Beilin and Mr. LIU Da as non -executive Directors; and (iii) Dr. LAM Sin


--- page 17 ---
Lai Judy, Mr. FANG Xiao and Ms. MA Andrea Lo Ling as proposed independent non -
executive Directors.